ABCL - AbCellera Biologics GAAP EPS of -$0.14 beats by $0.01 revenue of $9.95M misses by $0.9M
2024-05-07 16:31:09 ET
More on AbCellera Biologics
- AbCellera: Victim Of Its Own Success
- AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript
- AbCellera Biologics: Continuing To Expand Partnerships
- AbCellera partners with PE firms to develop antibody drugs, company creation
- AbCellera gains on antibody collaboration with Biogen